250 likes | 437 Views
Assess. Detect. Empower. Transforming Clinical Assessment. Earlier Diagnosis Targeted Treatment Better Functional Outcomes. The Invisible Disability. Brain Disorder: 1 in 3 Canadians. Brain injury is the leading cause of disability and death world-wide.
E N D
Transforming Clinical Assessment Earlier Diagnosis Targeted Treatment Better Functional Outcomes
The Invisible Disability Brain Disorder: 1 in 3 Canadians Brain injury is the leading cause of disability and death world-wide. (International Brain Injury Association) 85% of brain injuries are considered mild brain injuries MORE UNDETECTED
The Signature Injury from Combat 15-22% of combat-exposed Veterans have some kind of brain injury.
Where is the Need? NeuroInsights, 2010
Need to Measure NeuroFunction • Integrate cognition, mood, behaviour, sleep, nutrition, daily activities, quality of life. • Measure the more complex cognitive skills that are not being measured. • Standardization. • Functional outcome measurement.
What Our Competition Looks Like Traditional neurocognitive testing Used for most assessments.
Our Competition in Sport Computerized Tests
We are Medical Assessment with Brain Fitness Style Revolutionary opportunity for a database-driven, objective, functionally relevant clinical assessment. SharpBrains, 2010
Value to Health Professionals • Improved standard of care • 85 to 90 % reduction in time and cost • Profitable service stream • 35 – 60% gross profit
Go to Market Strategy ONLINE DEMO, WEBINAR, REFERRAL PROGRAM, MEDIA, SOCIAL MEDIA, CONFERENCES, DIRECT CALLS/MTGS ONLINE DEMO, WEBINAR, REFERRAL PROGRAM, MEDIA, SOCIAL MEDIA, CONFERENCES, DIRECT CALLS/MTGS ONT CANADAUSA
Development Plan 2012 2013 2014 2015 $3 Million (Series A) • BrainFx Screen Test • BrainFx Kids (ages 6-9) • BrainFx Dementia • BrainFx Professional • File further patents • Further international release $750K (Seed) • Provisional patent filed • Validation • FDA, CE Marking • Full marketing launch • More Research Studies • BrainFx 360 Release $585K (Founders & Govt Programs) • Assessment Development • Health Canada Cl.1 • Clinical trials coordinated • Back end services 19
Our Team Matthew Milner, CTO Tracy Milner, CEO Heather Condello, COO Scientific Advisors Dr. Donna Ouchterlony St. Michael’s Hospital Dr. Patricia Johnson Neuropsychologist • Software Devpt Project Manager • Systems Engineer • Enterprise Support for Microsoft Corporate Clients • Registered Occupational Therapists • Corporate management & start-up experience • Deep network in Ontario in neuroscience
Research Collaboration Government Funding & Advice Our Partners Professional Support
Key to Remember • We will cause an evolution for clinical assessment in health care • Deep experience & network • Born global by design • Super Charge our Launch
Thank you tmilner@brainfx.com 416.414.4626